A major new trial will test the efficacy of a new therapy for a disabling post-stroke condition that affects around 1 in 3 survivors. The study has received £1.26 million funding from the Efficacy and ...

In October 2024, WHO and partners, in collaboration with Member States, activated the Global Health Emergency Corps (GHEC) for the first time to provide support to countries facing mpox outbreaks.

Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, announced a substantial expansion of ...

Valanx Biotech, a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics discovery, and Fina Biosolutions LLC (FinaBio), experts in conjugate vaccine ...

Protega Pharmaceuticals Inc., an innovative specialty pharmaceutical company focused on responsible pain management and the development of novel abuse-deterrent products, announced that the US Food ...

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced positive topline results from its SL-1002 RAISE Limb Spasticity Trial (NCT05311215). The data were recently ...

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development, and diagnostics, has announced MSIntuit CRC v21, a next-generation AI solution.

Biocon Biologics said its drug substance facility in Bengaluru has been classified as voluntary action indicated by the US Food and Drug Administration. The company’s drug substance facility is ...

Novartis announced that Scemblix (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed Philadelphia chromosome-positive ...